EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Elective Neck Dissection in cT1‐4 N0M0 Submandibular Gland Cancer

Aman M. Patel, Sai D. Pamula, Mal Mehari, Shriyaus R. Lingam, Zavia D. King, Anusha P. Bharadia, Lukasz Czerwonka, Christopher C. Vanison

The Laryngoscope · 2026-11-05

DOI: 10.1002/lary.70998 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective To investigate occult nodal metastasis (ONM) and overall survival (OS) in patients undergoing elective neck dissection (END) for clinically node‐negative submandibular gland cancer (SMGC). Methods The 2006 to 2018 National Cancer Database was retrospectively reviewed for patients with cT1‐4 N0M0 SMGC undergoing surgical resection. Linear, binary logistic, Kaplan–Meier, and Cox proportional hazards regression models were implemented. Results A high proportion of patients were female ( N = 710, 54.6%) and White ( N = 1059, 82.5%) with adenoid cystic carcinoma histology ( N = 567, 43.6%) classified as cT1 ( N = 545, 41.9%). A minority of patients ( N = 255, 19.6%) underwent END. Academic/research reporting facility, high grade, cT3, and cT4 classification were associated with higher odds of undergoing END; Medicare insurance was associated with lower odds ( p < 0.05). ONM was identified in 63 (24.7%) patients undergoing END. The rate of ONM increased with cT classification (13.2% in cT1, 27.9% in cT2, 22.0% in cT3, and 50.0% in cT4) and grade (6.5% in well‐differentiated, 9.5% in moderately differentiated, and 40.3% in poorly differentiated). END was not associated with OS (hazard ratio [HR] 1.11, 95% confidence interval [CI] 0.84–1.46, p = 0.461). However, ONM was associated with worse OS (HR 3.69, 95% CI, 2.25–6.05, p < 0.001); 5‐year OS for patients without and with ONM was 83% and 50%, respectively ( p < 0.001). Conclusion END is performed frequently in SMGC but is not associated with OS. Although the rate of ONM approaches 25%, these findings suggest that END should not be routinely performed for prognostic purposes alone, especially in the absence of adverse features. Level of Evidence 4.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →